Exhibit 107
Calculation of Filing Fee Tables
FORM S-3
(Form Type)
AYTU BIOPHARMA, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | | | | | | | | | | | | | | | | |||||||||||
| Security |
| Security |
| Fee |
| Amount |
| Proposed |
| Maximum |
| Fee |
| Amount of |
| Carry |
| Carry |
| Carry |
| Filing Fee |
| ||||
Newly Registered Securities | | |||||||||||||||||||||||||||
Fees to Be Paid | | Equity | | Common Stock, par value $0.0001 per share | | 457 | (c) | 867,769 | | $ | 0.535 | (2) | $ | 464,257 | | | | $ | 43.04 | | | | | | | | | |
Fees Previously Paid | | — | | — | | — | | — | | | — | | | — | | — | | | — | | — | | — | | — | | — | |
Carry Forward Securities | | |||||||||||||||||||||||||||
Carry Forward Securities | | — | | — | | — | | — | | | — | | | — | | — | | | — | | — | | — | | — | | — | |
| | Total Offering Amounts | | | | | | | | — | | | | $ | 43.04 | | | | | | | | | | ||||
| | Total Fees Previously Paid | | | | | | | | | | | | $ | 0 | | | | | | | | | | ||||
| | Total Fee Offsets | | | | | | | | | | | | $ | 0 | | | | | | | | | | ||||
| | Net Fee Due | | | | | | | | | | | | $ | 43.04 | | | | | | | | | |
(1) | There are being registered hereunder 867,769 shares of our Common Stock that are issuable upon conversion of warrants to be offered by the selling stockholders named herein. Pursuant to Rule 416 under the Securities Act, this registration statement covers an indeterminate number of shares that may be issued upon stock splits, stock dividends or similar transactions. |
(2) | Estimated in accordance with Rule 457(c) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, based on the average of the high and low prices of shares of the registrant’s Common Stock, as reported on the Nasdaq Capital Market on June 6, 2022, a date within five business days prior to the initial filing of this registration statement. |
Table 2: Fee Offset Claims and Sources
N/A
Table 3: Combined Prospectuses
N/A